SEC Form 4 · accession 0001609351-18-000056
Spark Therapeutics, Inc. · ONCE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Vincent Milano
Director
Period of report
May 30, 2018
Accepted (ET)
May 31, 2018 · 9:32 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001609351
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | May 31, 2018 | M | 1,500 | — | A | 1,500 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F2 | $81.53 | May 30, 2018 | A | 4,000 | A | — | May 29, 2028 | Common Stock | 4,000 | 4,000 | D |
| Restricted Stock UnitsF3,F4 | — | May 30, 2018 | A | 1,500 | A | — | — | Common Stock | 1,500 | 1,500 | D |
| Restricted Stock UnitsF3,F5 | — | May 31, 2018 | M | 1,500 | D | — | — | Common Stock | 1,500 | 0 | D |
Explanation of responses
- F1Each restricted stock unit converted into one share of Spark Therapeutics, Inc. common stock.
- F2100% of the shares vest on the one-year anniversary of the grant date.
- F3Each restricted stock unit represents a contingent right to receive one share of Spark Therapeutics, Inc. common stock.
- F4100% of the restricted stock units vest on the one-year anniversary of the grant date. Vested shares will be delivered to the reporting person on the vesting date.
- F5On May 31, 2017, the reporting person was granted 1,500 restricted stock units that vest on the one-year anniversary of the grant date. Vested shares are delivered to the reporting person on the vesting date.